News - Cardio-vascular


Current filters:


Popular Filters

201 to 225 of 527 results

Bayer's Xarelto gains EU clearance for secondary prevention after ACS


German chemical and pharma group Bayer (BAYN: DE) says that its novel oral anticoagulant Xarelto (rivaroxaban)…

BayerCardio-vascularEuropeJohnson & JohnsonPharmaceuticalRegulationXarelto

Positive clinical results for Zensun's Neucardin CHF patients


USA and China-based Zensun Science & Technology has revealed positive results of four completed Phase…

Cardio-vascularNeucardinPharmaceuticalResearchSciClone PharmaZensun

Swedish registry questions superiority of bivalirudin over heparin in patients undergoing PCI for NSTE-ACS


Results from a large observational study reported at EuroPCR 2013 (the official annual meeting of the…

AngiomaxbivalirudinCardio-vascularheparinPharmaceuticalResearchThe Medicines Company

SciClone gains China rights to Zensun's Neucardin


USA-based SciClone Pharmaceuticals (Nasdaq: SCLN) today announced that the Company has entered into an…

Asia-PacificCardio-vascularLicensingNeucardinPharmaceuticalSciClone PharmaZensun

New study shows UCB's Neupro reduces NSBP in RLS patient


Leading Belgian drugmaker UCB (Euronext Brussels: UCB) today (May 17) announced data from a double-blind,…


Trevena and Forest Labs collaborate on TRV027 for acute heart failure


US GPCR ligand drug developer Trevena and Forest Laboratories (NYSE: FRX) have entered into a collaborative…

Cardio-vascularFinancialForest LaboratoriesLicensingPharmaceuticalTrevenaTRV027

Positive results from sub-analysis of Eliquis ARISTOTLE trial


US drug major Bristol-Myers Squibb (NYSE: BMY) and partner Pfizer (NYSE: PFE) reported results from a…

Bristol-Myers SquibbCardio-vascularEliquisPfizerPharmaceuticalResearch

Sanofi plans acceleration of expansion into Ukraine this year


French drug major Sanofi (Euronext: SAN) is considering expanding its presence in Ukraine this year,…

Cardio-vascularDiabetesEuropeMarkets & MarketingPharmaceuticalProductionSanofi

Bristol-Myers gets added indication from US FDA for Sustiva; signs second deal with Ambrx


US pharma major Bristol-Myers Squibb (NYSE: BMY) says that the US Food and Drug Administration has approved…

AmbrxAnti-viralsBiotechnologyBristol-Myers SquibbCardio-vascularDiabetesLicensingNorth AmericaPharmaceuticalRegulationSustiva

US FDA approves Merck & Co's combo cholesterol drug Liptruzet


The Food and Drug Administration has approved pharma giant Merck & Co's (NYSE: MRK) Liptruzet (ezetimibe…

atorvastatinCardio-vascularezetimibeLiptruzetMerck & CoNorth AmericaPharmaceuticalRegulation

FDA approves CSL's Kcentra and accepts Octapharma Octaplex BLA for reversal of anticoagulation


The US Food and Drug Administration has approved Kcentra (prothrombin complex concentrate, human) from…

BiotechnologyCardio-vascularCSL BehringCSL LimitedKcentraNorth AmericaOctapharmaOctaplexPharmaceuticalRegulation

Daiichi Sankyo to support Phase I clinical study of anticoagulant activity reverser for edoxaban


USA-based Perosphere and Japanese drug major Daiichi Sankyo(TYO: 4568) have entered into a clinical trial…

Cardio-vascularDaiichi SankyoedoxabanPER977PharmaceuticalResearch

Merck & Co opens new $120 million manufacturing plant in China


US Pharma giant Merck & Co (NYSE: MRK) has opened its new pharmaceutical manufacturing facility in Hangzhou,…

Asia-PacificCardio-vascularDiabetesFinancialMerck & CoPharmaceuticalProductionRespiratory and Pulmonary

Draft guidance from NICE recommends Bayer's Xarelto for PE and DVT


UK drugs watchdog the National Institute for Health and Care Excellence (NICE) this morning (April 19)…


US FDA accepts NDAs for Otsuka's tolvaptan and BTG's Varisolve


Japanese mid-sized drugmaker Otsuka Pharmaceutical (TYO: 4578) says that the US Food and Drug Administration…

BTGCardio-vascularNephrology and HepatologyNorth AmericaOtsukaPharmaceuticalRare diseasesRegulationtolvaptanVarisolve

Pivotal Therapeutics' Vascazen meets primary endpoint in Reveal trial


Canadian specialty pharma firm Pivotal Therapeutics (CNSX: PVO), with a focus on Omega-3 therapies for…

Cardio-vascularPharmaceuticalPivotal TherapeuticsResearchVascazen

Arrhythmia drug amiodarone "may increase cancer risk"


One of the most widely used drugs to treat arrhythmias, amiodarone, may increase the risk of developing…


Kowa and Daiichi Sankyo to end joint marketing partnership in Japan


Privately-held Japanese drugmaker Kowa and pharma major Daiichi Sankyo (TYO: 4568) say they will be ending…

Asia-PacificCardio-vascularDaiichi SankyoKowa PharmaceuticalsLicensingLivaloMarkets & MarketingOlmetecPharmaceutical

Germany's IQWiG finds considerable added benefit for Bristol-Myers/Pfizer's Eliquis


In an early benefit assessment under the German Act on the Reform of the Market for Medicinal Products…

Bristol-Myers SquibbCardio-vascularEliquisEuropePfizerPharmaceuticalPricingRegulation

Adherence to generic cholesterol-lowering drugs linked to fall in total care costs


People who regularly take statins to reduce high cholesterol will see lower hospitalization rates according…

Cardio-vascularFinancialGenericsMarkets & MarketingNorth America

201 to 225 of 527 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top